Close

Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: venBio Select Advisor LLC Sep 18, 2018 05:20PM
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC Jun 19, 2018 04:06PM
Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC Jun 15, 2018 02:05PM
Form 4 IMMUNOMEDICS INC For: Jun 15 Filed by: venBio Select Advisor LLC Jun 15, 2018 02:03PM
Form 4 IMMUNOMEDICS INC For: Nov 14 Filed by: venBio Select Advisor LLC Nov 16, 2017 11:47AM
View Older Stories

Nov 15, 2017 05:30PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Nov 9, 2017 04:10PM Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
Aug 16, 2017 04:00PM Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline
May 9, 2017 11:33AM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
May 5, 2017 08:49AM Immunomedics (IMMU) Announces $125M Private Placement of Convertible Preferred Stock; Outlines Strategic Steps to Drive Stockholder Value; CEO to Step Down
May 5, 2017 08:46AM Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value
Mar 17, 2017 05:16PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Mar 3, 2017 12:00PM Stockholders Endorse venBio’s Case for Meaningful Change at Immunomedics
Mar 3, 2017 10:19AM Immunomedics Board Institutes Measures As Stockholder Fiduciaries To Preserve Their Best Business Judgment To Protect The Rights Of All Stockholders
Mar 2, 2017 05:01PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Mar 2, 2017 01:52PM venBio Encourages Stockholders to Vote for Change at Immunomedics (IMMU)
Mar 2, 2017 01:51PM venBio Encourages Stockholders to Vote for Change
Mar 2, 2017 10:24AM Immunomedics (IMMU) Says Revised Settlement Offer Rejected By venBio
Mar 2, 2017 10:23AM Immunomedics Outlines Revised Settlement Offer Rejected By venBio; Announces Actions That Are In The Best Interests Of All Stockholders
Feb 27, 2017 08:00AM Immunomedics Issues Open Letter Highlighting the Clear Decision to Vote for Immunomedics to Ensure Continued Value Creation
Feb 22, 2017 05:05PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 22, 2017 08:32AM venBio Sends Letter to Immunomedics Stockholders
Feb 21, 2017 08:00AM Immunomedics Files Federal Lawsuit Against venBio for Continuing Material Violations of the Federal Securities Laws
Feb 15, 2017 05:26PM Form SC 13D/A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 15, 2017 04:15PM Immunomedics Sends Letter to Stockholders Highlighting Value Creating Global Licensing Agreement, Underscoring Fulfillment of Promise to Stockholders
Feb 14, 2017 04:47PM Immunomedics Comments on Baseless venBio Lawsuit
Feb 14, 2017 04:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 14, 2017 11:52AM venBio Takes Steps to Protect Immunomedics (IMMU) Stockholders Following Its Partnership with Seattle Genetics (SGEN)
Feb 14, 2017 11:50AM venBio Takes Steps to Protect Rights of Immunomedics Stockholders
Feb 10, 2017 05:16PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 10, 2017 04:14PM venBio Comments on Immunomedics Partnership Announcement
Feb 9, 2017 04:00PM Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments
Feb 7, 2017 05:01PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 7, 2017 12:45PM Immunomedics Strongly Encourages Stockholders to Reject the venBio Nominees — With Four New Independent Directors and a Robust Value-Maximization Process, Stockholders Should Not Risk Giving venBio
Feb 7, 2017 09:00AM Glass Lewis Endorses Full Slate of venBio Nominees at Immunomedics
Feb 6, 2017 05:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Feb 6, 2017 06:58AM ISS Endorses Full Slate of venBio Nominees at Immunomedics
Feb 2, 2017 04:15PM Immunomedics Mails Letter to Stockholders Highlighting Strength of New Board and Deep Engagement in Robust, Value-Creating Strategic and CMC Processes
Feb 1, 2017 02:22PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 30, 2017 05:02PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 30, 2017 09:00AM Immunomedics Sets the Record Straight in New Presentation
Jan 30, 2017 09:00AM venBio Calls on Immunomedics Stockholders to Support Meaningful Change
Jan 27, 2017 07:00AM Immunomedics Issues Statement to Stockholders and Files Investor Presentation
Jan 26, 2017 08:11AM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 26, 2017 08:00AM venBio Releases Presentation Detailing Urgent Case for Change at Immunomedics
Jan 24, 2017 07:00AM Immunomedics Mails Letter to Stockholders
Jan 18, 2017 05:16PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 18, 2017 03:02PM venBio Sends Letter to Immunomedics Stockholders
Jan 12, 2017 07:00AM Immunomedics to Mail Letter to Stockholders Highlighting Unprecedented Progress Toward Enhanced Value Creation
Jan 11, 2017 05:09PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 11, 2017 09:25AM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 11, 2017 09:00AM venBio Sends Letter to Immunomedics Stockholders
Jan 10, 2017 05:17PM Form DFAN14A IMMUNOMEDICS INC Filed by: venBio Select Advisor LLC
Jan 10, 2017 08:00AM venBio Responds to Immunomedics Announcement
Jan 9, 2017 06:00AM Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan
View Older Stories